PCSK9 and myocardial infarction: Here, we systematically reviewed the available scientific evidence of genetic variation on PCSK9 and assessed the efficacy of PCSK9 inhibitors in cardiovascular outcomes, including cardiovascular death, myocardial infarction, and stroke.